#USA #San Francisco #Value-Based Care #Arbital Health #Actuarial AI

Arbital Health Summit 2026: Shaping the Future of Healthcare

On March 19, 2026, Arbital Health successfully hosted its annual Summit focused on the future of value-based care and risk contracting in San Francisco. This prestigious invite-only event brought together over 150 leaders from the payer and provider segments to evaluate the current landscape of healthcare and the role of artificial intelligence (AI) in it.

The Gathering of Innovators

The Summit served as a pivotal platform for policymakers, payers, and healthcare providers to share insights and strategies in the realm of value-based care. Brian M. Overstreet, President and CEO of Arbital Health, stated, "The Arbital Summit is always a moment of truth for us—are we helping the industry solve its hardest risk-contracting problems?" The dialogues emphasized the successes and challenges within value-based care, revealing that while many organizations are making strides, they continue to struggle with demonstrating financial impact in a timely manner.

One key challenge discussed was the difficulty in translating actuarial data into tangible clinical outcomes, an issue that many attendees acknowledged hinders the advancement of effective risk contracting. Overstreet highlighted the importance of enhancing Actuarial AI infrastructures to support scalable value-based contracts, suggesting such advancements will unlock the next phase of care quality improvement.

High-Level Discussions on AI's Impact

Mark Gwynne, Chief Value Officer at UNC Health, reflected on the diverse perspectives shared by executives who intertwine strategic oversight with day-to-day operational execution. The blend of high-level thinking and practical insights made for engaging discussions, with participants gaining 'aha' moments, especially regarding AI's expansive role in healthcare.

Panelist Aneesh Chopra’s thought-provoking question, "Is AI inflationary or deflationary?" pushed attendees to think critically about the economic implications of implementing AI technologies. While it is clear that the operational complexities of risk-based contracting remain substantial, many speakers affirmed a notable shift in organizational approaches to seeking solutions.

Andrew C. Von Eschenbach, a panelist and former FDA Commissioner, pointed out that we are in an evolutionary period where AI will significantly reshape medical practices and data management. He stressed the importance of acquiring, aggregating, and analyzing data efficiently to improve patient care decisions.

Looking Toward the Future

Panelist Emily Brower, President & CEO of the National Association of ACOs, emphasized the need for Accountable Care Organizations (ACOs) to harness data effectively, showing clear evidence of successful patient pathways. Both Brower and Von Eschenbach underscored the importance of utilizing technology to enhance understanding of patient journeys, which could lead to more tailored and effective care options.

With 2026 marking a significant acceleration in value-based care, the ability to make quick and informed decisions is no longer merely advantageous but essential. Organizations that have adopted Actuarial AI platforms like Merlin AI are already noticing a performance edge, as these tools facilitate identification of cost drivers and optimize strategies to manage expenditures actively.

During the Summit, leaders in finance and clinical outcomes shared their experiences with Merlin AI in producing substantial results across their contract settlements, positively impacting millions of lives covered. The consensus among attendees was clear: to succeed in value-based care, organizations must leverage better data, sharper AI tools, and an enhanced understanding of performance drivers.

In essence, the Arbital Summit made it apparent that the organizations excelling in value-based healthcare are not waiting for ideal conditions to act. Instead, they are embracing data-driven insights and AI innovations to stay ahead of the curve.

Former Humana CIO Sam Deshpande aptly summarized the event's spirit by stating, "Value-based care holds the promise of meeting healthcare's greatest challenge—delivering high-quality care at an affordable cost." Arbital Health's commitment to building a robust Actuarial AI infrastructure signals promising developments on the horizon for the industry, as they look forward to engaging discussions in the year to come.

About Arbital Health

Arbital Health specializes in Actuarial AI-enabled infrastructure designed for providers and payers to effectively navigate risk-based contracts. By integrating leading value-based care actuaries with a comprehensive AI platform, the company aims to centralize fragmented data, enhance contract performance monitoring, and expedite decision-making processes. Merlin AI is Arbital’s innovative AI assistant, continuously measuring contract outcomes and providing actionable insights to lower costs and improve patient care outcomes. The company is guided by a team of seasoned healthcare professionals and is supported by prominent investors including Valtruis and Transformation Capital. For further details, visit Arbital Health's website.